Showing 1 - 4 results of 4 for search 'Shuying S Li', query time: 0.01s Refine Results
  1. 1
    FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells.

    FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells. by Xinxia Peng, Shuying S Li, Peter B Gilbert, Daniel E Geraghty, Michael G Katze

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.

    Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. by Shelly Karuna, Shuying Sue Li, Shannon Grant, Stephen R Walsh, Ian Frank, Martin Casapia, Meg Trahey, Ollivier Hyrien, Leigh Fisher, Maurine D Miner, April K Randhawa, Laura Polakowski, James G Kublin, Lawrence Corey, David Montefiori, HVTN 405/HPTN 1901 Study Team

    Published 2021-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Distinct immune responses in people living with HIV following SARS-CoV-2 recovery

    Distinct immune responses in people living with HIV following SARS-CoV-2 recovery by Dieter Mielke, Shuying Sue Li, Daniel J. Schuster, Xiaohong Li, Jiani Hu, Shelly Karuna, Kelly E. Seaton, Caroline Brackett, Brooke Dunn, Taylor Keyes, Adam Zalaquett, Sherry Stanfield-Oakley, Lu Zhang, Martina S. Wesley, Nathan Eisel, Nicole L. Yates, Xiaoying Shen, Lakshmanane Premkumar, Russell St. Germain, Anton M. Sholukh, Kristen Cohen, Stephen de Rosa, April Kaur Randhawa, John A. Hural, Lawrence Corey, M. Julianna McElrath, Georgia D. Tomaras, Ollivier Hyrien, Guido Ferrari

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

    A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13... by Zoe Moodie, Shuying Sue Li, Elena E. Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp, Shiyu Chen, Kelly E. Seaton, Sheetal S. Sawant, Lu Zhang, Jack Heptinstall, Shuying Liu, Nicole Grunenberg, Frank Tomaka, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Julie A. Ake, Sandhya Vasan, Giuseppe Pantaleo, Ian Frank, Lindsey R. Baden, Paul A. Goepfert, Michael Keefer, Mike Chirenje, Mina C. Hosseinipour, Kathryn Mngadi, Fatima Laher, Nigel Garrett, Linda-Gail Bekker, Stephen De Rosa, Erica Andersen-Nissen, James G. Kublin, Shan Lu, Peter B. Gilbert, Glenda E. Gray, Lawrence Corey, M. Juliana McElrath, Georgia D. Tomaras

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: